Gary Patou, Director: Xenon Pharmaceuticals XENE Sell · Filed 24/11/22

Trade details

Type: Insider sale
Amount: $117,204.61
Shares · price: 2,851 sh · $41.11 a share
Held after: 23,573 sh
Stock: Xenon Pharmaceuticals XENE
Person: Gary PatouDirector
Trade date: 24/11/22
Filed: 24/11/22
Days to filing: 0 days

Sold 10.8% of holdings

Share of holding sold: 10.8%

Xenon Pharmaceuticals trades, last 26 weeks

What else happened in Xenon Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/23~24/12/22

Gary Patou's recent trades

Gary PatouDirector
Sell10b5-1 planXenon Pharmaceuticals
Sell10b5-1 plan
Xenon Pharmaceuticals
XENE
$70.3K
1,322 sh
$70.3K
Filed 06/08
Traded 06/05
Gary PatouDirector
Planned sale10b5-1 planXenon Pharmaceuticals
Planned sale10b5-1 plan
Xenon Pharmaceuticals
XENE
$70.1K
1,322 sh
$70.1K
Filed 06/05
Traded 06/05
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$83.7K
2,040 sh
$83.7K
Filed 24/11/22
Traded 24/11/22
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$311.9K
7,598 sh
$311.9K
Filed 23/12/15
Traded 23/12/14
Gary PatouDirector
SellXenon Pharmaceuticals
Sell
Xenon Pharmaceuticals
XENE
$311.9K
7,598 sh
$311.9K
Filed 23/12/15
Traded 23/12/13